Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Monica Derrico is active.

Publication


Featured researches published by Monica Derrico.


International Journal of Std & Aids | 2006

Assessing sexually transmitted infections in a cohort of women living with HIV/AIDS, in Rio de Janeiro, Brazil

Beatriz Grinsztejn; Francisco I. Bastos; Valdilea G. Veloso; Ruth Khalili Friedman; José Henrique Pilotto; Mauro Schechter; Monica Derrico; Angela Cristina Vasconcelos de Andrade; Maria Cristina S. Lourenço; Ronaldo I. Moreira; Fabio Russomano; Mariza G. Morgado; Judith S. Currier

A cohort of 458 HIV-positive women under antiretroviral therapy has been followed at a reference hospital in Rio de Janeiro, Brazil. Most of them belong to impoverished social strata. Patients were screened for sexually transmitted infections (STIs) and gynaecologic conditions. Some STIs were found to be uncommon (e.g. chlamydial and gonococcal infections), while some conditions (bacterial vaginosis) and STIs, e.g. hepatitis B and human papilloma virus (HPV) infection, were found to be quite prevalent. The latter is of special concern, due to the high prevalence of HIV/HPV co-infection (∼51%) and its association with severe immunodeficiency, in a context of unacceptable high levels of uterine cancer and uneven gynaecological care. HIV-positive women are in need of comprehensive health services, including high-quality, regular, gynaecologic care in order to diagnose and treat lower genital tract infections and prevent the evolution of HPV-related lesions. Reproductive counselling should be a part of this approach.


Drugs-education Prevention and Policy | 1999

Drug Use and the Spread of HIV/AIDS in South America and the Caribbean

Cio Bastos; Steffanie A. Strathdee; Monica Derrico

We review available data on drug use with respect to the spread of HIV/AIDS in South America and the Caribbean. Although many information gaps remain, the emerging picture clearly shows the signi® cant role of both injected cocaine and crack cocaine in the Brazilian epidemic, and the increasingly large role of injecting cocaine in the Southern Cone. The Caribbean and the Andean regions are thus far spared from extensive diffusion of injecting drugs and its consequences. However,these regions are now experiencing a signi® cant transition, in terms of an increasing role of crack cocaine in the Caribbean HIV/AIDS epidemic, and the recent introduction of heroin and initiation of drug injection in the Andean region. Harm-reduction strategies are being implemented for the ® rst time in recent years after a long delay, but remain primarily restricted to Brazil, and to a lesser extent, Argentina. Yet even in these settings, harm-reduction programmes such as needle-exchange programmes face considerable challenges with respect to restrictive legislation and lack of broader support.


Revista De Saude Publica | 2010

HIV rapid testing as a key strategy for prevention of mother-to-child transmission in Brazil

Valdilea G. Veloso; Francisco I. Bastos; Margareth Crisóstomo Portela; Beatriz Grinsztejn; Esau Joao; José Henrique Pilotto; Ana Beatriz Busch Araújo; Breno Santos; Rosana Fonseca; Regis Kreitchmann; Monica Derrico; Ruth Khalili Friedman; Cynthia Braga da Cunha; Mariza G. Morgado; Karin Nielsen Saines; Yvonne J. Bryson

OBJECTIVE To assess the feasibility of HIV rapid testing for pregnant women at maternity hospital admission and of subsequent interventions to reduce perinatal HIV transmission. METHODS Study based on a convenience sample of women unaware of their HIV serostatus when they were admitted to delivery in public maternity hospitals in Rio de Janeiro and Porto Alegre, Brazil, between March 2000 and April 2002. Women were counseled and tested using the Determine HIV1/2 Rapid Test. HIV infection was confirmed using the Brazilian algorithm for HIV infection diagnosis. In utero transmission of HIV was determined using HIV-DNA-PCR. There were performed descriptive analyses of sociodemographic data, number of previous pregnancies and abortions, number of prenatal care visits, timing of HIV testing, HIV rapid test result, neonatal and mother-to-child transmission interventions, by city studied. RESULTS HIV prevalence in women was 6.5% (N=1,439) in Porto Alegre and 1.3% (N=3.778) in Rio de Janeiro. In Porto Alegre most of women were tested during labor (88.7%), while in Rio de Janeiro most were tested in the postpartum (67.5%). One hundred and forty-four infants were born to 143 HIV-infected women. All newborns but one in each city received at least prophylaxis with oral zidovudine. It was possible to completely avoid newborn exposure to breast milk in 96.8% and 51.1% of the cases in Porto Alegre and Rio de Janeiro, respectively. Injectable intravenous zidovudine was administered during labor to 68.8% and 27.7% newborns in Porto Alegre and Rio de Janeiro, respectively. Among those from whom blood samples were collected within 48 hours of birth, in utero transmission of HIV was confirmed in 4 cases in Rio de Janeiro (4/47) and 6 cases in Porto Alegre (6/79). CONCLUSIONS The strategy proved feasible in maternity hospitals in Rio de Janeiro and Porto Alegre. Efforts must be taken to maximize HIV testing during labor. There is a need of strong social support to provide this population access to health care services after hospital discharge.OBJETIVO: Analisar a viabilidade da testagem rapida para o HIV entre gestantes na admissao a maternidade e de intervencoes para reduzir a transmissao perinatal do HIV. METODOS: Amostra de conveniencia de mulheres que desconheciam sua situacao sorologica para o HIV quando admitidas para o parto em maternidades publicas do Rio de Janeiro, RJ, e de Porto Alegre, RS, entre marco de 2000 e abril de 2002. As mulheres foram aconselhadas e testadas com teste rapido Determine HIV1/2 na maternidade. Infeccao pelo HIV foi confirmada pelo algoritmo brasileiro para o diagnostico da infeccao pelo HIV. A transmissao intra-utero foi determinada pelo PCR-DNA-HIV. Foram realizadas analises descritivas dos dados sociodemograficos, numero de gestacoes e de abortos previos, numero de visitas de pre-natal, momento da testagem para o HIV, resultado do teste rapido para o HIV, intervencoes recebidas pelos recem-natos e de transmissao vertical do HIV, de acordo com cada cidade. RESULTADOS: A prevalencia de HIV entre as mulheres foi 6,5% (N=1.439) em Porto Alegre e 1,3% (N=3.778) no Rio de Janeiro. A maioria foi testada durante o trabalho de parto em Porto Alegre e no pos-parto, no Rio de Janeiro. Cento e quarenta e quatro criancas nasceram de 143 mulheres infectadas pelo HIV. Todos os recem-natos receberam ao menos a profilaxia com zidovudina oral, exceto um em cada cidade. Foi possivel evitar qualquer exposicao ao leite materno em 96,8% e 51,1% dos recem-natos em Porto Alegre e no Rio de Janeiro, respectivamente. A zidovudina injetavel foi administrada durante o trabalho de parto para 68,8% dos recem-natos em Porto Alegre e 27,7% no Rio de Janeiro. Entre aqueles com amostras de sangue coletadas ate 48 horas do nascimento, a transmissao intra-utero foi confirmada em quatro casos no Rio de Janeiro (4/47) e em seis casos em Porto Alegre (6/79). CONCLUSOES: A estrategia mostrou-se factivel nas maternidades do Rio de Janeiro e de Porto Alegre. Esforcos devem ser empreendidos para maximizar a testagem durante o trabalho de parto. Forte suporte social precisa ser acoplado a essa estrategia para garantir o acesso dessa populacao ao sistema de saude apos a alta da maternidade.


American Journal of Obstetrics and Gynecology | 2015

Predictors of early menopause in HIV-infected women: a prospective cohort study.

Guilherme Amaral Calvet; Beatriz Grinsztejn; Marcel de Souza Borges Quintana; Monica Derrico; Emilia Moreira Jalil; Andrea Cytryn; Angela Cristina Vasconcelos de Andrade; Ronaldo I. Moreira; Marcelo Ribeiro Alves; Valdiléa Gonçalves Veloso dos Santos; Ruth Khalili Friedman

OBJECTIVE This study sought to investigate the age at natural menopause and its predictors in a cohort of human immunodeficiency virus (HIV)-infected women in Rio de Janeiro, Brazil. STUDY DESIGN HIV-infected women ≥30 years of age were included. Menopause was defined as having ≥1 year since the last menstrual period. Early age at natural menopause was defined as the onset of menopause at ≤45 years of age. Multivariate Cox proportional hazards analysis was applied. RESULTS A total of 667 women were included, and the median age at baseline was 34.9 years (interquartile range, 30.9-40.5 years). In all, 507 (76%) women were premenopausal, and 160 (24%) reached menopause during the observational period; of these, 36 of 160 (27%) had early menopause. The median age at natural menopause was 48 years (interquartile range, 45-50 years). Menarche at <11 years of age (hazard ratio [HR], 2.03; 95% confidence interval [CI], 1.23-3.37), cigarette smoking during the observational period (HR, 1.59; 95% CI, 1.08-2.33), chronic hepatitis C virus (HCV) infection (HR, 2.53; 95% CI, 1.27-5.07), and CD4 count <50 cells/mm(3) (HR, 3.07; 95% CI, 1.07-8.80) were significantly associated with an earlier age at natural menopause. The magnitudes of the effects of menarche at <11 years of age (HR, 2.7; 95% CI, 1.23-5.94), cigarette smoking during the observational period (HR, 3.00; 95% CI, 1.39-6.45), chronic HCV infection (HR, 6.26; 95% CI, 2.12-18.52), and CD4 count <50 cells/mm(3) (HR, 6.64; 95% CI, 1.91-23.20) were much higher and significantly associated with early natural menopause. CONCLUSION Early natural menopause was frequent among the HIV-infected women. In addition to menarche and cigarette smoking, which are menopausal factors among women in general, HIV-related immunodeficiency and chronic HCV were additional predictors for an earlier age at natural menopause. Adequate management of HIV in women is critical, as early onset of menopause has been associated with increased morbidity and mortality.


PLOS ONE | 2014

Factors Associated with Tobacco Smoking and Cessation among HIV-Infected Individuals under Care in Rio de Janeiro, Brazil

Thiago Silva Torres; Paula M. Luz; Monica Derrico; Luciane Velasque; Eduarda Grinsztejn; Valdilea G. Veloso; Sandra W. Cardoso; Marilia Santini-Oliveira; Beatriz Grinsztejn; Raquel De Boni

Worldwide the prevalence of smoking among people living with HIV/AIDS is elevated compared to the general population. This probably reflects the cluster of individual characteristics that have shared risk factors for HIV infection and smoking. A cross-sectional study, enrolling a convenience sample from a Brazilian HIV clinical cohort was conducted to evaluate the prevalence of tobacco smoking and the factors associated with current smoking and abstinence. A total of 2,775 HIV-infected individuals were interviewed: 46.2% have never smoked, 29.9% were current smokers and 23.9% were former smokers. Current smokers had a higher prevalence of alcohol and illicit drug use when compared to the other two groups. A higher proportion of heterosexual individuals were former smokers or never smokers while among men who have sex with men (MSM) a higher proportion were current smokers. Former smokers had been more frequently diagnosed with high blood pressure, diabetes mellitus, cardiovascular diseases and depression, while for current smokers lung diseases were more frequent. Former smokers and current smokers were more likely to have had any hospital admission (42.0% and 41.2%, respectively) than participants who never smoked (33.5%) (p<0.001). Multivariate model results showed that current smokers (versus never smokers) were more likely to be less educated, to report the use of alcohol, crack and cocaine and to present clinical comorbidities. Former smokers (versus current smokers) were more likely to be older, to have smoked for a shorter amount of time and to have smoked >31 cigarettes/day. MSM (compared to heterosexuals) and cocaine users (versus non-users) had lower odds of being former smokers. Considering our results, smoking cessation interventions should be tailored to younger individuals, MSM and substance users.


Brazilian Journal of Infectious Diseases | 2014

Cascade of access to interventions to prevent HIV mother to child transmission in the metropolitan area of Rio de Janeiro Brazil.

Elaine S. Pires Araujo; Ruth Khalili Friedman; Luis Antonio Bastos Camacho; Monica Derrico; Ronaldo I. Moreira; Guilherme Amaral Calvet; Marilia Santini de Oliveira; Valdilea G. Veloso; José Henrique Pilotto; Beatriz Grinsztejn

OBJECTIVES To describe the access to the interventions for the prevention of Human Immunodeficiency Virus (HIV) mother to child transmission and mother to child transmission rates in the outskirts of Rio de Janeiro, from 1999 to 2009. METHODS This is a retrospective cohort study. Prevention of HIV mother to child transmission interventions were accessed and mother to child transmission rates were calculated. RESULTS The study population is young (median: 26 years; interquartile range: 22.0-31.0), with low monthly family income (40.4% up to one Brazilian minimum wage) and schooling (62.1% less than 8 years). Only 47.1% (n=469) knew the HIV status of their partner; of these women, 39.9% had an HIV-seronegative partner. Among the 1259 newborns evaluated, access to the antenatal, intrapartum and postpartum prevention of HIV mother to child transmission components occurred in 59.2%, 74.2%, and 97.5% respectively; 91.0% of the newborns were not breastfed. Overall 52.7% of the newborns have benefited from all the recommended interventions. In subsequent pregnancies (n=289), 67.8% of the newborns received the full package of interventions. The overall rate of HIV vertical transmission was 4.7% and the highest annual rate occurred in 2005 (7.4%), with no definite trend in the period. CONCLUSIONS Access to the full package of interventions for the prevention of HIV vertical transmission was low, with no significant trend of improvement over the years. The vertical transmission rates observed were higher than those found in reference services in the municipality of Rio de Janeiro and in the richest regions of the country.


Journal of Clinical Virology | 1999

Anti-HIV-1 seroreactivity and HIV transmission route[R1]

Vera Bongertz; Monick Lindenmeyer Guimarães; M.F.G Soares-da-Costa; Valdilea G. Veloso; Francisco I. Bastos; Célia Landmann Szwarcwald; Monica Derrico; Paulo Roberto Telles; J.H Pilloto; Ec João Filho; Mariza G. Morgado

Background: antibody binding assays carried out by our group have consistently indicated a higher reactivity of sera from male HIV-1 infected individuals. This study was carried out in order to analyze the importance of gender, route of transmission, disease progression and HIV-1 genotype in seroreactivity assays. Study design: specificity of antibody binding was studied in plasma of 247 HIV-1 seropositive individuals belonging to patient groups of pregnant women, injecting drug users (IDUs) and recent seroconvertors, resident in Rio de Janeiro, RJ. Recognition of synthetic peptides corresponding to antigenically important epitopes in the envelope of HIV-1 (gp41 immunodominant epitope, V3 loop, V2 loop and gp41 735‐752 epitope) was determined. Results: the immunodominant gp41 peptide (amino acids 594‐613, HIV-1 MN sequence) was recognized by 85% of all plasma tested. Reactivity with the gp41 735‐752 peptide and gp120 V2 loop peptides was low but quite variable, being generally more often specific to a Brazilian V2 peptide used than to the HIV-1 MN derived V2 peptide. The overall recognition of the different V3 peptides tested varied from 41 to 76%. Patients with more advanced disease showed a more frequent reactivity with the peptides studied than did asymptomatic patients. Statistically significant differences in peptide recognition were observed by multiple logistic analyses comparing plasma derived from individuals infected by blood or sexual HIV transmission, adjusting for disease progression and gender. Plasma from individuals infected by sexual transmission showed lower peptide recognition than did plasma from individuals infected through HIV positive blood. Association attempts between seroreactivity and genotype indicated that plasma derived from patients infected with HIV-1 of the F subtype showed highest recognition of


PLOS ONE | 2016

The Men Who Have Sex with Men HIV Care Cascade in Rio de Janeiro, Brazil

Rodolfo Castro; Marcelo Ribeiro-Alves; Renato Girade Corrêa; Monica Derrico; Kátia Regina Valente de Lemos; Jose Roberto Grangeiro; Beto de Jesus; Denise Pires; Valdilea G. Veloso; Beatriz Grinsztejn

Brazil has a concentrated HIV epidemic and men who have sex with men (MSM) are disproportionately affected. Yet, no data is available on the HIV care cascade for this population. This study aimed to assess the HIV care cascade among MSM newly diagnosed through innovative testing strategies in Rio de Janeiro. Data from 793 MSM and travestites/transgender women (transwomen) tested for HIV at a non-governmental LGBT organization and a mobile testing unit located at a gay friendly venue were analyzed. A 12-month-after-HIV-diagnosis-censored cohort was established using CD4, viral load and combination antiretroviral therapy (cART) longitudinal data from those diagnosed with HIV. A cross-sectional HIV care cascade was built using this data. The relative risks of achieving each cascade-stage were estimated using generalized linear models according to age, self-declared skin-color, education, history of sexually transmitted diseases (STD), drug use and prior HIV testing. From Jan-2013 to Jan-2014, 793 MSM and transwomen were tested, 131 (16.5%) were HIV-infected. As of January 2015, 95 (72.5%) were linked to HIV care, 90 (68.7%) were retained in HIV care, 80 (61.1%) were on cART, and 50 (38.2%) were virally suppressed one year after HIV diagnosis. Being non-white (Relative risk [lower bound; upper bound of 95% confidence interval] = 1.709 [1.145; 2.549]) and having a prior HIV-test (1.954 [1.278; 2.986]) were associated with an HIV-positive diagnosis. A higher linkage (2.603 [1.091; 6.211]) and retention in care (4.510 [1.880; 10.822]) were observed among those who were older than 30 years of age. Using community-based testing strategies, we were able to access a high-risk MSM population and a small sample of transwomen. Despite universal care coverage and the test-and-treat policy adopted in Brazil, the MSM cascade of care indicates that strategies to increase linkage to care and prompt cART initiation targeted to these populations are critically needed. Interventions targeting non-white and young MSM should be prioritized.


BMC Cancer | 2015

A cross-sectional study of high-risk human papillomavirus clustering and cervical outcomes in HIV-infected women in Rio de Janeiro, Brazil

Jessica L. Castilho; José Eduardo Levi; Paula M. Luz; Mary Catherine Cambou; Tazio Vanni; Angela de Andrade; Monica Derrico; Valdilea G. Veloso; Beatriz Grinsztejn; Ruth Khalili Friedman

BackgroundIn Brazil, the rate of cervical cancer remains high despite the availability of screening programs. With ongoing vaccine development and implementation, information on the prevalence of specific HPV types is needed, particularly among high-risk populations, such as HIV-infected women.MethodsWe performed a study of HIV-infected women in Rio de Janeiro, Brazil, who underwent cervical HPV genotype testing between 2005-2013. We examined the prevalence of high-risk HPV types and the patterns of high-risk HPV type clustering. Using logarithmic binomial regression, we estimated the risk of abnormal cytology by HPV genotype result.ResultsOf the 562 women included, 498 (89 %) had at least one HPV type detected. 364 women (65 %) had at least one high-risk HPV type detected and 181 (32 %) had more than one high-risk type detected. HPV 58 was the most frequent HPV type detected overall (prevalence 19.8 % [95 % confidence interval 16.4–23.1]), followed by HPV 53 (prevalence 15.5 % [12.5–18.5]) and HPV 16 (prevalence 13 % [10.2–15.8]). Women infected with more than one high-risk HPV type were younger, had lower CD4+ lymphocyte counts, and were more likely to be infected with HPV 16 or 18. In adjusted analyses, presence of more than one high-risk HPV type was associated with a two-fold increased risk of abnormal cytology after adjusting for presence of individual high-risk type, age, and CD4+ lymphocyte count (adjusted prevalence ratios 1.88–2.07, all p <0.001). No single high-risk HPV type was statistically associated with abnormal cytology after adjusting for the presence of more than one high-risk HPV type.ConclusionsIn the largest study of cervical HPV genotypes among HIV-infected women in Latin America, infection by high-risk HPV types other than 16 or 18 and infection by more than one high-risk HPV types were common. Infection by more than one high-risk type was more strongly associated with abnormal cervical cytology than any individual high-risk HPV type, highlighting the need for multi-valent HPV vaccines.


PLOS ONE | 2014

Absence of effect of menopause status at initiation of first-line antiretroviral therapy on immunologic or virologic responses: a cohort study from Rio de Janeiro, Brazil

Guilherme Amaral Calvet; Luciane Velasque; Paula M. Luz; Sandra W. Cardoso; Monica Derrico; Ronaldo I. Moreira; Angela Cristina Vasconcelos de Andrade; Andrea Cytryn; Elaine Pires; Valdilea G. Veloso; Beatriz Grinsztejn; Ruth Khalili Friedman

Objective To compare the effectiveness of first-line combination antiretroviral therapy (cART) between premenopausal and postmenopausal women. Methods ART-naïve women initiating cART between January 2000/June 2010 at the Instituto de Pesquisa Clínica Evandro Chagas Cohort were studied. Women were defined as postmenopausal after 12 consecutive months of amenorrhea. CD4 cell counts and HIV-1 RNA viral load (VL) measurements were compared between pre- and postmenopausal at 6, 12 and 24 months after cART initiation. Women who modified/discontinued a drug class or died due to an AIDS defining illness were classified as ART-failures. Variables were compared using Wilcoxon test, χ2 or Fisher’s exact test. The odds of cART effectiveness (VL<400 copies/mL and/or no need to change cART) were compared using logistic regression. Linear model was used to access relationship between CD4 change and menopause. Results Among 383 women, 328 (85%) were premenopausal and 55 (15%) postmenopausal. Median pre cART CD4 counts were 231 and 208 cells/mm3 (p = 0.14) in pre- and postmenopausal women, respectively. No difference in the median pre cART VL was found (both 4.8 copies/mL). Median CD4 changes were similar at 6 and 12 months. At 24 months after cART initiation, CD4 changes among postmenopausal women were significantly lower among premenopausal women (p = 0.01). When the analysis was restricted to women with VL<400 copies/mL, no statistical difference was observed. Overall, 63.7% achieved cART effectiveness at 24 months without differences between groups at 6, 12 and 24 months. Conclusion Menopause status at the time of first-line cART initiation does not impact CD4 cell changes at 24 months among women with a virologic response. No relationship between menopause status and virologic response was observed.

Collaboration


Dive into the Monica Derrico's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Paula M. Luz

Oswaldo Cruz Foundation

View shared research outputs
Researchain Logo
Decentralizing Knowledge